Capricor Therapeutics Announces Positive Topline Results from Pivotal Phase 3 HOPE-3 Study of Deramiocel in Duchenne Muscular Dystrophy
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 12/21/10 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 12/06/10 | Current report filing |
|
4 | ||
| 11/12/10 | Quarterly report pursuant to Section 13 or 15(d) |
|
32 | ||
| 08/17/10 | SEC-generated letter |
|
1 | ||
| 08/16/10 | Quarterly report pursuant to Section 13 or 15(d) |
|
34 | ||
| 08/09/10 | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
3 | ||
| 08/05/10 | SEC-generated letter |
|
2 | ||
| 07/28/10 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 07/28/10 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 07/28/10 | Statement of changes in beneficial ownership of securities |
|
2 |